Sign in

CIK 0001526119 · Non-accelerated filer<br>Smaller reporting company

Verastem, Inc.

Sign in to watch
Ticker
VSTM
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
MA
Entity type
operating
EIN
273269467
Phone
(781) 292-4200
Business address
117 KENDRICK STREET, SUITE 500, NEEDHAM, MA, 02494
  1. 4 Open-market sale Chief Financial Officer sold 91 shares at an average $6.93 ($631)
  2. 4 Open-market sale President and CEO sold 244 shares at $6.95 ($1,696)
  3. 4 Open-market sale Director sold 284 shares at $6.95 ($1,974)
  4. 4 Open-market sale Director sold 593 shares at $6.95 ($4,121)
  5. 4 Open-market sale President and CEO sold 858 shares at $5.70 ($4,891)
  6. 3 Insider Initial Statement of Ownership
  7. 4 Open-market sale President and CEO sold 8,568 shares at $5.24 ($44,896)
  8. 4 Grant or award Chief Financial Officer acquired 38,800 shares (grant or award)
  9. 4 Open-market sale Chief Financial Officer sold 6 shares at $6.94 ($42)
  10. 4 Open-market sale Chief Financial Officer sold 93 shares at an average $4.21 ($392)
  11. 4 Open-market sale Director sold 415 shares at an average $4.49 ($1,862)
  12. 4 Open-market sale Director sold 929 shares at an average $4.48 ($4,161)
  13. 4 Open-market sale President and CEO sold 427 shares at an average $4.47 ($1,907)
  14. 4 Open-market sale President and CEO sold 812 shares at $3.84 ($3,118)
  15. 4 Open-market sale Chief Financial Officer sold 6 shares at $2.86 ($17)
  16. 4 Open-market sale Chief Financial Officer sold 93 shares at an average $2.76 ($257)
  17. 4 Open-market sale Director sold 131 shares at $2.79 ($365)
  18. 4 Open-market sale President and CEO sold 184 shares at $2.79 ($513)
  19. 4 Open-market sale Director sold 336 shares at $2.79 ($937)
  20. 4 Open-market sale Director sold 287 shares at $2.80 ($804)

Page 4 of 27 · 526 filings